The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin

BACKGROUND: We used 2-deoxy-2-[(18)F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate the FDG uptake in patients with advanced and/or metastatic soft tissue sarcoma (STS) undergoing therapy with Ecteinascidin-743 (ET-743, Trabectedin, Yondelis™). PATIENTS AND METHODS: The pilot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Bernd, Schmitt, Thomas, Wuchter, Patrick, Dimitrakopoulou-Strauss, Antonia, Ho, Anthony D., Egerer, Gerlinde
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763103/
https://www.ncbi.nlm.nih.gov/pubmed/19841717
http://dx.doi.org/10.3390/md7030331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763103/
https://www.ncbi.nlm.nih.gov/pubmed/19841717
http://dx.doi.org/10.3390/md7030331

Ejemplares similares